BridgeBio Pharma IncEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 85.55 USD | 93,415 USD | 42,09 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 105,257 USD | 10 | 6 | 3 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 195.861.242 | 14,68 | 5,11 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name BridgeBio Pharma Inc
Mitarbeiter 834
Handelsplatz NASDAQ
Ticker Symbol BBIO
IPO Datum 2019-06-27
Adresse 3160 Porter Drive, Palo Alto, CA, United States, 94304
Webseite https://bridgebio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Neil Kumar Ph.D. | Co-Founder, CEO & Director |
| 2 | Dr. Thomas Trimarchi Ph.D. | CFO & President |
| 3 | Dr. Charles J. Homcy M.D. | Co-Founder, Chairman of Pharmaceuticals & Lead Director |
| 4 | Dr. Frank P. McCormick Ph.D. | Co-Founder, Chairman of Oncology & Director |
| 5 | Ms. Maricel M. Apuli | Chief Accounting Officer |
| 6 | Dr. Uma Sinha Ph.D. | Chief Scientific Officer |
| 7 | Dr. Richard H. Scheller Ph.D. | Chairman of Research & Development |
| 8 | Mr. Eli M. Wallace Ph.D. | Chief Scientific Officer of Oncology |
| 9 | Dr. Eric Michael David J.D., M.D., Ph.D. | Chief Executive Officer of Gene Therapy |
| 10 | Mr. Matthew Outten CPC, MBA | Chief Commercial Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Kohlberg Kravis Roberts & Co LP | 0,00% | 0,00 Mio. USD |
| 4 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 5 | Viking Global Investors LP | 0,00% | 0,00 Mio. USD |
| 6 | Farallon Capital Management, L.L.C. | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Aisling Capital Management LP | 0,00% | 0,00 Mio. USD |
| 10 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 13 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 15 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 16 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 17 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 18 | Polar Capital Holdings PLC | 0,00% | 0,00 Mio. USD |
| 19 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 20 | Franklin Resources Inc | 0,00% | 0,00 Mio. USD |